ENQUIRY
PAY FEES
ANNOUNCEMENTS
Shri Vile Parle Kelavani Mandal's
INSTITUTE OF PHARMACY, DHULE
Approved by PCI, AICTE, DTE
Affiliated to DBATU, Lonere & MSBTE Mumbai
  (02562) 297802, 297602
  iopdhule@svkm.ac.in  
Shri Vile Parle Kelavani Mandal's
INSTITUTE OF PHARMACY, DHULE
Approved by PCI, New Delhi, DTE, Mumbai, Government of Maharashtra
Affiliated to DBATU, Lonere & MSBTE Mumbai

FACULTY

Dr. Yogeeta Goyal Agrawal

Professor & HOD

Qualification: M. Pharm., Ph.D.

Specialization: Pharmaceutics Email ID: yogeeta.goyal@svkm.ac.in

Phone: +91-9421270813

Experience: 16 Years

  • 30.04.2021 – Present:
    Institute : Shri Vile Parle Kelavani Mandal’s Institute of Pharmacy, Dhule, MH
    Position : Professor of Pharmaceutics
  • 1.02.2013 – 29.04.2021 (8.2 years): Institute : R.C Patel Institute of Pharmaceutical Education and Research, Shirpur.
    Position : Associate Professor of Pharmaceutics (23.04.2018 – 30.04.2021)
    Assistant Professor of Pharmaceutics (01.02.2013 – 22.04.2018)
  • 1.01.2011-30.01.2013(2 Years):
    Institute: All India Institute of Medical Sciences
    Position: Senior Research fellow
  • 20.06.2009-30.07.2011(2.1 Years)
    Institute: I.E.C College of Pharmacy, Greater–Noida
    Position: Assistant Professor
  • 1.07.2004-31.01.2007(2.6 Years)
    IPCA Pharma, Nagpur headquarter
    Position: Professional Service Officer

Interest Areas: Nanotechnology

Research:

  • Publications:
    • International: 27
    • National: 03
  • Books: Nil
  • Book Chapters: Nil
  • Patents: 01
  • Presentations:
    • International: 02
    • National: 12
  • Completed Government Funded Projects: 01(24 Lacs) 1. Role: Principal Investigator
    Area of Project: Nanotechnology
    Name of Governing Body: DBT, Govt. of India

Industry Projects:

Completed: Nil
Ongoing: Nil

Conferences/Workshops/Seminars attended: 42

Academic Activities:

Ph.D.: Awarded: Nil Registered: 05

M. Pharm Guided: 21

B. Pharm Guided: 40

Awards:

  • Stood First in the order of Merit in the M.S University during Masters in Pharmacy.
  • Gold Medal by MSU Pharmacy Alumina Association at Post Graduation level for securing the highest percentage in University.
  • Gold Medal by Indian Pharmaceutical Association (IPA) at Graduation level for securing the highest percentage in university.
  • Received Nine Gold Medals from Nagpur University for securing the highest marks in each subject from different sponsors.
  • G. P. Nair Award from Indian Drug Manufacturers Association(IDMA) for university topper in RTM Nagpur Univ. in B Pharmacy
  • Received Outstanding Performance award on the basis of API Evaluation in R.C Patel Institute of Pharmaceutical Education and Research, Shirpur for the academic year 2017-18.
  • Received Outstanding Performance award on the basis of API Evaluation in SVKMs Institute for Pharmacy, Dhule for the academic year 2021-22.

Professional Membership:

1. Indian Pharmaceutical Association (Life Time membership MAH/DHUL/LM/0032)

2. The Association of Pharmaceutical Teachers of India (Life Time membership MA/LM-2494)

3. Registered Pharmacist under Maharashtra State Pharmacy Council (Certificate No-74757)

4. MSU Pharmacy Alumni Association (Life time membership)

Recent Publications:

1. Premkumar S. Baviskar, Hitendra S. Mahajan, Sachin M. Chandankar, Yogeeta O. Agrawal, Development and evaluation of N-acetyl glucosamine-decorated vitamin-E-based micelles incorporating resveratrol for cancer therapy,Journal of Drug Delivery Science and Technology,Volume 78,2022,103965,ISSN 1773-2247.(Impact Factor 5.062)

2. Yogeeta O. Agrawal, Kiran D. Patil, Kamini R. More, Mohd Usman Mohd Siddique, Saad Alkahtani, Nada H. Aljarba, Md Saquib Hasnain, Amelioration of bioavailability through formulating and optimizing Azilsartan Entrapped nanostructured lipid carriers and its pharmacokinetic assessment,Journal of Drug Delivery Science and Technology,Volume 77,2022,103894,ISSN 1772247.(Impact Factor 5.062)

3. Prajapati C, Agrawal YO, Agnihotri VV, Mahajan UB, Patil KR, Patil DD, Patil CR. Development and biological evaluation of protective effect of kidney targeted N-acetylated chitosan nanoparticles containing thymoquinone for the treatment of DNA damage in cyclophosphamide-induced haemorrhagic cystitis. Int J Biol Macromol. 2022 Aug 1;214:391-401.(Impact factor 8.025)

4. Agrawal YO, Husain M, Patil KD, Sodgir V, Patil TS, Agnihotri VV, Mahajan HS, Sharma C, Ojha S, Goyal SN. Verapamil hydrochloride loaded solid lipid nanoparticles: Preparation, optimization, characterisation, and assessment of cardioprotective effect in experimental model of myocardial infarcted rats. Biomed Pharmacother. 2022 Oct; 154: 113429. (Impact factor 7.419)

5. Shirsath K, Agrawal YO, Nose to brain targeting of Nanoemulsions for Parkinson’s disease: Pathways, Challenges, and recent techniques. CNS & Neurological Disorders - Drug Targets, Accepted (Impact factor 4.388)

6. Husain M, Agnihotri VV, Goyal SN, Agrawal YO, Development, optimization and characterization of hydrocolloid based mouth dissolving film of Telmisartan for the treatment of hypertension, Food Hydrocolloids for Health, Volume 2,2022,100064

7. Agrawal YO, Patil P, Patil K, Mahajan HS, Shah D, Gujarathi N. Development, Characterization, In-vitro and pharmacokinetic evaluation of Xa inhibitor Apixaban Loaded Nanostructured Lipid Carriers Optimized by Quality-By-Design Approach, Accepted, Drug Delivery, 2022 Jan 3 (Impact Factor-6.64)

8. Pawar HD, Mahajan UB, Nakhate KT, Agrawal YO, Patil CR, Meeran MFN, Sharma C, Ojha S, Goyal SN. Curcumin Protects Diabetic Mice against Isoproterenol-Induced Myocardial Infarction by Modulating CB2 Cannabinoid Receptors. Life. 2022; 12(5):624. https://doi.org/10.3390/life12050624 (Impact Factor-3.817)

9. Eddin LB, Jha NK, Goyal SN, Agrawal YO, Subramanya SB, Bastaki SMA, Ojha S. Health Benefits, Pharmacological Effects, Molecular Mechanisms, and Therapeutic Potential of α-Bisabolol. Nutrients. 2022 Mar 25;14(7):1370. doi: 10.3390/nu14071370. (Impact Factor-5.719)

10. Agrawal Y, Patil K, Mahajan H, Potdar M, Joshi P, Nakhate K, Sharma C, Goyal SN, Ojha S. In vitro and in vivo characterization of Entacapone-loaded nanostructured lipid carriers developed by quality-by-designapproach, Drugdelivery,29,1(2022):1112-1121. doi:10.1080/10717544.2022.2058651 (Impact Factor-6.64)

11. Husain M, Agrawal YO. Antimicrobial Remedies and Emerging Strategies for the Treatment of Diabetic Foot Ulcers, Accepted, Current Diabetes Reviews, 24 Jan 2022

12. Agrawal YO, Mahajan UB, Agnihotri VV, Nilange MS, Mahajan HS, Sharma C, Ojha S, Patil CR, Goyal SN. Ezetimibe-Loaded Nanostructured Lipid Carrier Based Formulation Ameliorates Hyperlipidaemia in an Experimental Model of High Fat Diet. Molecules. 2021 Mar 9;26(5):1485 (Impact factor-3.267)

13. Agrawal YO., Mahajan H.S., Mahajan U. B, Ojha S.Methotrexate-Loaded Nanostructured Lipid Carrier Gel Alleviates Imiquimod-Induced Psoriasis by Moderating Inflammation: Formulation, Optimization, Characterization, In-Vitro and In-Vivo Studies. Int J Nanomedicine 2020 Jul 7; 15:4763-4778. (Impact factor-5.12)

14. Redasani VK, Agrawal YO, Jagtap MS, Mahajan HS and Surana SJ. Analytical Method Development and Validation of Flecainide Acetate by Chromatographic and Spectrophotometric Techniques. Medicinal and Analytical chemistry 2020 December 08;4(2): ISSN 2639-2534.

Copyright 2024 SVKM's INSTITUTE OF PHARMACY. All Rights Reserved.   Privacy Policy   Terms of Use
Admission Enquiry
Name *
Email *
Mobile *
Query / Comments *